Ban on substitutive dispensing acts may boost illicit deals.

Published: 2000-10-23 11:58:00

Updated: 2000-10-23 11:58:00

Since the medical and pharmacy role separation system was lauanched, many illicit business practices in drug trades have been prevailed in the market. Even drug companies provided unlawful rebates to medical institutes in order to induce more prescription for their own products in the market. It ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK